- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Vascularity, elastography in suspicious TIRADS scores may differentiate malignant thyroid nodules
Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting on the island of Oahu determined that assessing the vascularity and elastography in suspect TIRADS categories can efficiently diagnose malignancy of thyroid nodules. Acknowledging that sonographic TIRADS scoring remains the first method of imaging assessment for diagnosing malignant...
Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting on the island of Oahu determined that assessing the vascularity and elastography in suspect TIRADS categories can efficiently diagnose malignancy of thyroid nodules.
Acknowledging that sonographic TIRADS scoring remains the first method of imaging assessment for diagnosing malignant thyroid nodules, “we assessed the added value of shear-wave elastography (SWE) to classic TIRADS assessment,” said Leila Aghaghazvini, MD, from the department of radiology at Shariati Hospital and Iran’s University of Medical Sciences in Tehran.
In this ARRS Annual Meeting Cum Laude award-winning Online Poster, 200 total thyroid nodules were assessed by conventional sonography to ascertain TIRADS score and pertinent descriptors. Using a 7.5 MHz probe to asses vascularity pattern and resistive index (RI), elastography evaluations were performed quantitatively via color mapping and calculating mean and maximum velocities in shear-wave modality. Final diagnoses of all thyroid nodules were confirmed by histopathology assessment or follow-up imaging.
According to Aghaghazvini et al., patient mean age was 53 years; 105 were men [52.5%]. And of 27 [13.5%] total nodules with malignancy in their study, 14 [7%] were papillary thyroid carcinoma, 11 [5.5%] were follicular thyroid carcinoma, and 2 [1%] were medullary thyroid cancer. AUC of the ROC curve for TIRADS assessment was 0.76. Results found 37 [18.5%] TIRADS 4 nodules, wherein 15 [40.5%] were malignant, and 57 [28.5%] TIRADS 5 nodules, 12 [21.1%] of which were malignant.
In only TIRADS 4 nodules, Doppler grade AUC, RI, color map elastography grade, SWE maximum velocity, and mean SWE velocity for diagnosing malignancy were 0.8, 0.93, 0.89, 0.86, and 0.82, respectively. Meanwhile, profiles in TIRADS 5-only nodules were 0.8, 0.96, 0.85, 0.96, and 0.97, respectively. Additionally, in TIRADS 4, an RI cutoff point of 0.6 yielded diagnostic efficacy indices of 0.93, 1, 0.97, 1, and 0.96 for sensitivity, specificity, efficiency, PPV and NPV, respectively. In TIRADS 5 nodules, a cutoff point of 4.33 for SWE mean velocity yielded diagnostic efficacy indices of 1, 0.82, 0.86, 0.6, and 1 for sensitivity, specificity, efficiency, PPV and NPV, respectively.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751